FDA Adverse Event Injury Summary report: N

CENTRIMAG BLOOD PUMP

MDR report key: 23547846 · Received November 13, 2025

Report

Report Number
3003306248-2025-00321
Event Type
Injury
Date Received
November 13, 2025
Date of Event
October 13, 2025
Report Date
December 29, 2025
Manufacturer
THORATEC SWITZERLAND GMBH
Product Code
QNR
UDI-DI
07640135140627
PMA / PMN Number
K020271
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
BIOMEDICAL ENGINEER
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MANUFACTURER¿S INVESTIGATION CONCLUSION: CLOTTING WAS UNABLE TO BE CONFIRMED AS THE DEVICE WAS NOT RETURNED FOR EVALUATION, AND NO PHOTOS WERE SUBMITTED. A DIRECT CORRELATION BETWEEN THE REPORTED EVENTS AND THE CENTRIMAG BLOOD PUMP COULD NOT BE CONCLUSIVELY DETERMINED THROUGH THIS EVALUATION. IT WAS REPORTED THAT FLOW INITIALLY HAD TO BE SET QUITE HIGH IN ORDER TO GET ANY FLOW AND WAS THEN ABLE TO COME BACK DOWN A BIT. FLOW WAS LOST AGAIN COMPLETELY A FEW HOUR LATER, AND THE CENTRIMAG CIRCUIT WAS EXCHANGED. THERE WAS SOME CLOTTING IN THE VENOUS CANNULA. THERE WAS NOTED TO BE A CORRELATION IN HEMODYNAMICS. MULTIPLE ATTEMPTS WERE MADE TO OBTAIN ADDITIONAL INFORMATION FROM THE CUSTOMER REGARDING THE EVENT; HOWEVER, NO ADDITIONAL INFORMATION WAS PROVIDED. THE CENTRIMAG BLOOD PUMP WAS NOT RETURNED FOR EVALUATION. THE SERIAL NUMBER OR OTHER IDENTIFYING INFORMATION OF THE PRODUCT WAS NOT REPORTED AND WAS NOT ABLE TO BE DETERMINED DURING THE INVESTIGATION. THE CENTRIMAG BLOOD PUMP INSTRUCTIONS FOR USE (IFU) (REV. C) LISTS VENOUS THROMBOEMBOLISM AND ARTERIAL NON-CNS (NON-CENTRAL NERVOUS SYSTEM) THROMBOEMBOLISM AS ADVERSE EVENTS THAT MAY BE ASSOCIATED WITH THE USE OF THE CENTRIMAG BLOOD PUMP. THE IFU CONTAINS THE FOLLOWING ADDITIONAL WARNINGS AND CAUTIONS: IFU WARNING #7: IT IS INTENDED THAT SYSTEMIC ANTICOAGULATION BE UTILIZED WHILE THIS DEVICE IS IN USE. ANTICOAGULATION LEVELS SHOULD BE DETERMINED BY THE PHYSICIAN BASED ON RISKS AND BENEFITS TO THE PATIENT. IFU WARNING #10: FREQUENT PATIENT AND DEVICE MONITORING IS RECOMMENDED. IFU CAUTION #2: THIS DEVICE SHOULD ONLY BE USED BY PERSONS THOROUGHLY TRAINED IN EXTRACORPOREAL CIRCULATION PROCEDURES. IFU CAUTION #9: MONITOR CAREFULLY FOR ANY SIGNS OF OCCLUSION THROUGHOUT THE CIRCUIT. IFU CAUTION #15: ALWAYS HAVE A BACKUP CENTRIMAG PUMP, CONSOLE, MOTOR, AND ACCESSORIES AVAILABLE FOR USE. THE CURRENT REVISIONS OF THE INSTRUCTIONS FOR USE (IFU) AND OPERATION MANUAL CAN ALSO BE FOUND ON THE ELECTRONIC IFU PAGE OF THE ABBOTT WEBSITE. NO FURTHER INFORMATION WAS PROVIDED. THE MANUFACTURER IS CLOSING THE FILE ON THIS EVENT.

Additional Manufacturer Narrative · 0

A4 - PATIENT WEIGHT WAS NOT PROVIDED BY CUSTOMER. NO FURTHER INFORMATION WAS PROVIDED. A SUPPLEMENTAL REPORT WILL BE SUBMITTED ONCE THE MANUFACTURER'S INVESTIGATION IS COMPLETE.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE FLOW HAD TO BE SET "QUITE HIGH" IN ORDER TO GET IT TO FLOW AT ALL, THEN COME BACK DOWN A BIT. A FEW HOURS LATER IN CARDIOVASCULAR, FLOWS WERE LOST AGAIN AND HAD TO SWITCH TO ANOTHER CIRCUIT. THERE WAS SOME CLOTTING IN THE VENOUS CANNULA. IT WAS NOTED THERE WAS ALSO A CORRELATION BETWEEN HEMODYNAMICS AND THE EVENT. THE CENTRIMAG CONSOLE WAS EXCHANGED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1983653 CENTRIMAG BLOOD PUMP BLOOD PUMP FOR ECMO, LONG-TERM (> 6 HOURS) USE QNR THORATEC SWITZERLAND GMBH 102953 07640135140627

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention